BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22957490)

  • 1. A case of systemic allergic dermatitis caused by inhaled budesonide: cross-reactivity in patch tests with the novel inhaled corticosteroid ciclesonide.
    Salava A; Alanko K; Hyry H
    Contact Dermatitis; 2012 Oct; 67(4):244-6. PubMed ID: 22957490
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to inhalation corticosteroids.
    Baeck M; Pilette C; Drieghe J; Goossens A
    Eur J Dermatol; 2010; 20(1):102-8. PubMed ID: 19825528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deflazacort hypersensitivity: a difficult-to-manage case of systemic allergic dermatitis and literature review.
    Bianchi L; Hansel K; Antonelli E; Bellini V; Rigano L; Stingeni L
    Contact Dermatitis; 2016 Jul; 75(1):54-6. PubMed ID: 27264291
    [No Abstract]   [Full Text] [Related]  

  • 4. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic contact dermatitis caused by prednicarbate presenting as chronic hand eczema.
    Otero-Rivas MM; Ruiz-González I; Pérez-Bustillo A; Rodríguez-Prieto MÁ
    Contact Dermatitis; 2015 Jul; 73(1):51-2. PubMed ID: 25864447
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma.
    Bennett ML; Fountain JM; McCarty MA; Sherertz EF
    Am J Contact Dermat; 2001 Dec; 12(4):193-6. PubMed ID: 11753891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact sensitivity and cross-reactivity of budesonide.
    Noda H; Matsunaga K; Noda T; Abe M; Ohtani T; Shimizu Y; Asahi K; Iida Y; Takigami N; Masutani M
    Contact Dermatitis; 1993 Apr; 28(4):212-5. PubMed ID: 8508630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis.
    Vega F; Ramos T; Las Heras P; Blanco C
    Cutis; 2016 Jan; 97(1):24-7. PubMed ID: 26919353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact allergy to inhaled budesonide.
    García AP; Tovar V; de Barrio M; Villanueva A; Tornero P
    Contact Dermatitis; 2008 Jul; 59(1):60-1. PubMed ID: 18598312
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactions to systemic corticosteroids in patients contact sensitized to budesonide.
    Hansel K; Marietti R; Bianchi L; Tramontana M; Foti C; Romita P; Stingeni L
    Contact Dermatitis; 2020 Oct; 83(4):321-324. PubMed ID: 32386100
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to induce sensitization to budesonide in the guinea pig.
    Isaksson M; Bruze M
    Contact Dermatitis; 2003 Jan; 48(1):50-2. PubMed ID: 12641581
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis in response to budesonide reactivated by inhalation of the allergen.
    Isaksson M; Bruze M
    J Am Acad Dermatol; 2002 Jun; 46(6):880-5. PubMed ID: 12063485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airborne allergic contact dermatitis due to budesonide from professional exposure.
    Corazza M; Baldo F; Osti F; Virgili A
    Contact Dermatitis; 2008 Nov; 59(5):318-9. PubMed ID: 18976387
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids.
    Baeck M; Soria A; Marot L; Theate I; Hendrickx E; Van Belle A; Goossens A; Tennstedt D; Dachelet C; Jaeger J; Pilette C; Renauld JC; Van Baren N; Rozières A; Nicolas JF; Dumoutier L
    Contact Dermatitis; 2013 Jun; 68(6):357-68. PubMed ID: 23692036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD
    Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythema-multiforme-like contact dermatitis from budesonide.
    Stingeni L; Caraffini S; Assalve D; Lapomarda V; Lisi P
    Contact Dermatitis; 1996 Feb; 34(2):154-5. PubMed ID: 8681557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.